Targeted disruption of the BCL9/beta-catenin complex in colorectal cancer using stapled peptide
Project/Area Number |
23890169
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Gastroenterology
|
Research Institution | Sapporo Medical University |
Principal Investigator |
|
Project Period (FY) |
2011 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥3,250,000 (Direct Cost: ¥2,500,000、Indirect Cost: ¥750,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 抗大腸癌ペプチド / BCL9 / Wnt シグナル / Wntシグナル |
Research Abstract |
We developed a stabilized a helix of BCL9 (SAH-BCL9), which we show targets beta-catenin, dissociates native beta-catenin/BCL9 complexes, selectively suppresses Wnt transcription, and exhibits mechanism-based antitumor effects. SAH-BCL9also suppresses tumor growth, angiogenesis, invasion, and metastasis in mouse xenograft models of Colo320 colorectal carcinoma. By inhibiting the BCL9/beta-catenin interaction and selectively suppressing oncogenic Wnt transcription, SAH-BCL9 may serve as a prototypetherapeutic agent for cancers driven by deregulated Wnt signaling.
|
Report
(3 results)
Research Products
(24 results)
-
[Journal Article] TRIM13(RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NFKappa B pathway and proteasome activity.2013
Author(s)
Gatt ME, Takada K, Mani M, Lerner M, Pick M, Hideshima T, Carrasco DE, Protopopov A, Ivanova E, Sangfelt O, Grander D, Barlogie B, Shaughessy JD Jr, Anderson KC, Carrasco DR
-
Journal Title
Br J Haematol
Volume: 162
Issue: 2
Pages: 210-220
DOI
Related Report
Peer Reviewed
-
[Journal Article] A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide excision repair (NER) as potential chemoresistance marker.2013
Author(s)
Hirakawa M, Sato Y, Ohnuma H, Takayama T, Sagawa T, Nobuoka T, Harada K, Miyamoto H, Sato Y, Takahashi Y, Katsuki S, Hirayama M, Takahashi M, Ono M, Maeda M, Takada K, Hayashi T, Sato T, Miyanishi K, Takimoto R, Kobune M, Hirata K, Kato J
-
Journal Title
Cancer Chemother Pharmacol
Volume: 71
Issue: 3
Pages: 789-797
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Targeted Disruption of the BCL9/・-catenin Complex Inhibits Oncogenic Wnt Signaling.2012
Author(s)
Takada K, Zhu D, Bird GH, Sukhdeo K, Zhao JJ, Mani M, Lemieux M, Carrasco DE, Ryan J, Horst D, Fulcinti M, Munshi NC, Xu W, Kung AL, Shivdasani RA, Walensky LD, Carrasco DR
-
Journal Title
Sci Transl Med
Volume: 4(148)
Issue: 148
Pages: 148-117
DOI
Related Report
Peer Reviewed
-
[Journal Article] Diagnostic validity of CT gastrography versus gastroscopy for primary lesions in gastric cancer: evaluating the response to chemotherapy, a retrospective analysis.2012
Author(s)
Takahashi S, Hirayama M, Kuroiwa G, Kawano Y, Takada K, Sato T, Miyanishi K, Sato Y, Takimoto R, Kobune M, Kato J.
-
Journal Title
Related Report
Peer Reviewed
-
[Journal Article] Stromal cells expressing hedgehog-interacting protein regulate the proliferation of myeloid neoplasms.2012
Author(s)
Kobune M, Iyama S, Kikuchi S, Horiguchi H, Sato T, Murase K, Kawano Y, Takada K, Ono K, Kamihara Y, Hayashi T, Miyanishi K, Sato Y, Takimoto R, Kato J.
-
Journal Title
Blood Cancer J
Volume: 2
Issue: 9
Pages: e87-e87
DOI
Related Report
Peer Reviewed
-
[Journal Article] UGT1A1*28 and *6polymorphisms and nilotinib-induced unconjugated hyperbilirubinemia in a Japanese patient with chronic myelogenous leukemia.2012
Author(s)
Takada K, Sato T, Iyama S, Ono K, Kamihara Y, Murase K, Kawano Y, Hayashi T, Miyanishi K, Sato Y, Kobune M, Takimoto R, Kato J
-
Journal Title
Int Canc Conf J201
Volume: 1
Pages: 220-223
Related Report
Peer Reviewed
-
[Journal Article] Targeting anticancer drug delivery to pancreatic cancer cells using a fucose-bound nanoparticle approach.2012
Author(s)
Yoshida M, Takimoto R, Murase K, Sato Y, Hirakawa M, Tamura F, Sato T, Iyama S, Osuga T, Miyanishi K, Takada K, Hayashi T, Kobune M, Kato J.
-
Journal Title
PLoS One
Volume: 7(7)
Issue: 7
Pages: e39545-e39545
DOI
Related Report
Peer Reviewed
-
[Journal Article] Successful treatment bu fibrin glue sealant for pneumothorax with chronic GVHD resistant to autologous blood patch pleurodesis.2012
Author(s)
Iyama S, Sato T, Murase K, Kikuchi S, Kamihara Y, Ono K, Takada K, Miyanishi K, Sato Y, Takimoto R, Kobune M, Obama T, Miyajima M, Watanabe A, Higami T, Hirayama Y, Kato J.
-
Journal Title
Intern Med
Volume: 51(15)
Pages: 2011-2014
Related Report
Peer Reviewed
-
-
[Journal Article] Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox.2012
Author(s)
Kikuchi S, Kobune M, Iyama S, Sato T, Murase K, Kawano Y, Takada K, Ono K, Kaneko Y, Miyanishi K, Sato Y, Hayashi T, Takimoto R, Kato J.
-
Journal Title
Free Radic Biol Med
Volume: 23(6)
Issue: 4
Pages: 548-550
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-